First International Bank & Trust’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$237K Buy
+1,024
New +$209K 0.08% 49
2025
Q2
Sell
-1,425
Closed -$299K 64
2025
Q1
$299K Sell
1,425
-176
-11% -$34.2K 0.09% 58
2024
Q4
$284K Sell
1,601
-208
-11% -$38.2K 0.09% 57
2024
Q3
$357K Buy
1,809
+180
+11% +$33.6K 0.11% 52
2024
Q2
$279K Sell
1,629
-583
-26% -$96.6K 0.1% 58
2024
Q1
$403K Hold
2,212
0.14% 44
2023
Q4
$343K Sell
2,212
-1,435
-39% -$209K 0.13% 48
2023
Q3
$544K Sell
3,647
-1,354
-27% -$199K 0.2% 31
2023
Q2
$674K Buy
5,001
+55
+1% +$8.06K 0.21% 30
2023
Q1
$788K Buy
4,946
+44
+0.9% +$6.73K 0.26% 24
2022
Q4
$792K Buy
4,902
+47
+1% +$7.21K 0.27% 25
2022
Q3
$651K Buy
4,855
+661
+16% +$94.9K 0.24% 34
2022
Q2
$643K Buy
4,194
+890
+27% +$136K 0.24% 34
2022
Q1
$536K Sell
3,304
-451
-12% -$65.5K 0.18% 41
2021
Q4
$508K Buy
+3,755
New +$444K 0.18% 42

Other funds holding ABBV

First International Bank & Trust's ABBV Position: Q3 2025 in Review

First International Bank & Trust opened a new position in AbbVie (ABBV) in Q3 2025: 1,024 shares worth $237K. The stake represents 0.08% of the portfolio and ranks #49 among its holdings. This is a return to the name: First International Bank & Trust previously reported a position in ABBV as recently as Q1 2025.

First International Bank & Trust first reported a position in ABBV in Q4 2021 and has held it in 15 quarters since. The position peaked at $792K in Q4 2022. 3,906 funds tracked by Wall St. Rank hold ABBV as of Q3 2025.

  • First International Bank & Trust held 1,024 shares of AbbVie worth $237K as of Q3 2025.
  • AbbVie was a new First International Bank & Trust position in Q3 2025.
  • AbbVie made up 0.08% of First International Bank & Trust's portfolio in Q3 2025, its #49 holding.
  • First International Bank & Trust first reported a position in AbbVie in Q4 2021 and has held it in 15 quarters since.
  • First International Bank & Trust's AbbVie position peaked at $792K in Q4 2022.
  • 3,906 funds tracked by Wall St. Rank held AbbVie as of Q3 2025.

Based on First International Bank & Trust's 13F filing for Q3 2025, filed 7 Oct 2025.